22:58:22 EST Thu 29 Jan 2026
Enter Symbol
or Name
USA
CA



Dolby Laboratories Reports First Quarter 2026 Financial Results

2026-01-29 16:15 ET - News Release

Dolby Laboratories Reports First Quarter 2026 Financial Results

PR Newswire

SAN FRANCISCO, Jan. 29, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the first quarter of fiscal 2026.

"With a good start to the fiscal year, we are optimistic about our position in the market and confident in our growth opportunities," said Kevin Yeaman, President and CEO, Dolby Laboratories. "We continue to have strong momentum with Dolby Atmos and Dolby Vision, while also expanding our addressable market with our imaging patent program for content streamers and Dolby OptiView."

First Quarter Fiscal 2026 Financial Highlights

  • Total revenue was $347 million, compared to $357 million for the first quarter of fiscal 2025.
  • GAAP net income was $53 million or $0.55 per diluted share, compared to GAAP net income of $68 million or $0.70 per diluted share for the first quarter of fiscal 2025. On a non-GAAP basis, first quarter net income was $103 million or $1.06 per diluted share, compared to $111 million or $1.14 per diluted share for the first quarter of fiscal 2025.
  • Dolby repurchased approximately one million shares of its common stock for approximately $70 million, and ended the quarter with approximately $207 million of stock repurchase authorization available going forward.

A complete listing of Dolby's non-GAAP measures are described and reconciled to the corresponding GAAP measures at the end of this release.

Recent Business Highlights

  • Over 35 auto OEMs now embrace Dolby Atmos - from luxury vehicles to entry level models with baseline audio systems.
  • Mercedes-Benz is one of the first automakers to enable Spatial Audio with Dolby Atmos in Apple CarPlay, which will be supported across its latest line up, including the all-new electric GLC, CLA, and GLB.
  • Mahindra announced the first vehicle in India to support Dolby Atmos and Dolby Vision.
  • Qualcomm is integrating Dolby's latest technology into its Gen 5 Snapdragon Automotive platform.
  • Peacock is the first streamer to embrace Dolby's full suite of advanced picture and sound innovations, including Dolby Vision 2. Peacock also announced that it is extending the availability of Dolby Vision and Dolby Atmos across live sports over the coming year, including Sunday Night Football, the NBA, and MLB.
  • Hisense, TCL, and TP Vision announced various upcoming TV models that will support Dolby Vision 2.
  • LG unveiled its LG Sound Suite, a modular home audio system powered by Dolby Atmos FlexConnect, including the world's first soundbar to feature the technology.
  • Meta began supporting Dolby Vision on Facebook after recently announcing support for Dolby Vision on Instagram.

Dividend

Today, Dolby announced a cash dividend of $0.36 per share of Class A and Class B common stock, payable on February 18, 2026, to stockholders of record as of the close of business on February 10, 2026.

Financial Outlook

Dolby's financial outlook relies, in part, on estimates of royalty-based revenue that take into consideration various factors that are subject to uncertainty, including consumer demand for electronic products. In addition, actual results could differ materially from the estimates Dolby is providing herein due in part to uncertainty resulting from the macroeconomic effect of certain conditions, including developments concerning trade restrictions and changes in trade or diplomatic relationships, supply chain constraints, international conflicts, geopolitical instability, and fluctuations in inflation and interest rates. The uncertainty resulting from these factors has greatly reduced visibility into Dolby's future outlook. To the extent possible, the estimates Dolby is providing for future periods reflect certain assumptions about the potential impact of certain of these items, based upon a consideration of currently available external and internal data and information. These assumptions are subject to risks and uncertainties. For more information, see "Forward-Looking Statements" in this press release for a description of certain risks that Dolby faces, and the section captioned "Risk Factors" in its Quarterly Report on Form 10-Q for the first quarter of fiscal 2026, to be filed on or around the date hereof.

Dolby is providing the following estimates for its second quarter of fiscal 2026:

  • Total revenue is estimated to range from $375 million to $405 million.
  • Licensing revenue is estimated to range from $350 million to $380 million.
  • Gross margins are anticipated to be approximately 90% on a GAAP basis and approximately 91% on a non-GAAP basis.
  • Operating expenses are anticipated to range from $230 million to $240 million on a GAAP basis and from $195 million to $205 million on a non-GAAP basis.
  • Effective tax rate is anticipated to be around 23% on a GAAP basis and around 21% on a non-GAAP basis.
  • Diluted earnings per share is anticipated to range from $0.94 to $1.09 on a GAAP basis and from $1.29 to $1.44 on a non-GAAP basis.

Dolby is providing the following estimates for the full year of fiscal 2026:

  • Total revenue is expected to range from $1.4 billion to $1.45 billion.
  • Licensing revenue is estimated to range from $1.295 billion to $1.345 billion.
  • Gross margins are anticipated to be approximately 88% on a GAAP basis and approximately 90% on a non-GAAP basis.
  • Operating expenses are anticipated to range from $930 million to $950 million on a GAAP basis and from $780 million to $800 million on a non-GAAP basis.
  • Dolby expects operating margins to be approximately 21% on a GAAP basis and to be approximately 34% on a non-GAAP basis.
  • Effective tax rate is anticipated to be around 23% on a GAAP basis and around 21% on a non-GAAP basis.
  • Diluted earnings per share is anticipated to range from $2.71 to $2.86 on a GAAP basis and from $4.30 to $4.45 on a non-GAAP basis.

Conference Call Information

Members of Dolby management will lead a conference call open to all interested parties to discuss first quarter fiscal 2026 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Thursday, January 29, 2026. Access to the teleconference will be available at http://investor.dolby.com or by dialing 1-888-210-2212 (+1-646-960-0390 for international callers) and entering confirmation code 5587811.

A replay of the call will be available from 5:00 p.m. PT (8:00 p.m. ET) on Thursday, January 29, 2026, until 8:59 p.m. PT (11:59 p.m. ET) on Thursday, February 5, 2026 by dialing 1-800-770-2030 (+1-647-362-9199 for international callers) and entering the confirmation code 5587811. An archived version of the teleconference will also be available on the Dolby website, http://investor.dolby.com.

Non-GAAP Financial Information

To supplement Dolby's financial statements presented on a GAAP basis, Dolby management uses, and Dolby provides to investors, certain non-GAAP financial measures as an additional tool to evaluate Dolby's operating results in a manner that focuses on what Dolby's management believes to be its ongoing business operations and performance. We believe these non-GAAP financial measures are also helpful to investors in enabling comparability of operating performance between periods and among peer companies. Additionally, Dolby's management regularly uses our supplemental non-GAAP financial measures to make operating decisions, for planning and forecasting purposes and determining bonus payouts. Specifically, Dolby excludes the following as adjustments from one or more of its non-GAAP financial measures:

Stock-based compensation expense: Stock-based compensation, unlike cash-based compensation, utilizes subjective assumptions in the methodologies used to value the various stock-based award types that Dolby grants. These assumptions may differ from those used by other companies. To facilitate more meaningful comparisons between its underlying operating results and those of other companies, Dolby excludes stock-based compensation expense.

Amortization of acquisition-related intangibles: Dolby amortizes intangible assets acquired in connection with business combinations. These intangible assets consist of patents and technology, customer relationships, and other intangibles. Dolby records amortization charges relating to these intangible assets in its GAAP financial statements, and Dolby views these charges as items arising from pre-acquisition activities that are determined by the timing and valuation of its acquisitions. As these amortization charges do not directly correlate to its operations during any particular period, Dolby excludes these charges to facilitate an evaluation of its current operating performance and comparisons to its past operating results. In addition, while amortization expense of acquisition-related intangible assets is excluded from Non-GAAP Net Income, the revenue generated from those assets is not excluded.

Restructuring charges or credits: Restructuring charges are costs associated with restructuring plans and primarily relate to costs associated with exit or disposal activities, employee severance benefits, and asset impairments. Dolby excludes restructuring costs, including any adjustments to charges recorded in prior periods (which may be credits), as Dolby believes that these costs are not representative of its normal operating activities and therefore, excluding these amounts enables a more effective comparison of its past operating performance and to that of other companies.

Income tax adjustments: The income tax effects of the aforementioned non-GAAP adjustments do not directly correlate to its operating performance so Dolby believes that excluding such income tax effects provides a more meaningful view of its underlying operating results to management and investors.

Using the aforementioned adjustments, Dolby provides various non-GAAP financial measures including, but not limited to: non-GAAP net income, non-GAAP diluted earnings per share, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating margin, and non-GAAP effective tax rate. Dolby's management believes it is useful for itself and investors to review both GAAP and non-GAAP measures to assess the performance of Dolby's business, including

as a means to evaluate period-to-period comparisons. Dolby's management does not itself, nor does it suggest that investors should, consider non-GAAP financial measures in isolation from, superior to, or as a substitute for, financial information prepared in accordance with GAAP. Whenever Dolby uses non-GAAP financial measures, it provides a reconciliation of the non-GAAP financial measures to the most closely applicable GAAP financial measures. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures as detailed above and below. Investors are also encouraged to review Dolby's GAAP financial statements as reported in its US Securities and Exchange Commission (SEC) filings. A reconciliation between GAAP and non-GAAP financial measures is provided at the end of this press release and on the Dolby investor relations website, http://investor.dolby.com.

Forward-Looking Statements

Certain statements in this press release and in our earnings calls, including, but not limited to, expected financial results for the second quarter of fiscal 2026 and full year fiscal 2026, Dolby's ability to expand existing business, navigate challenging periods, pursue its long-term growth opportunities, and advance its other long-term objectives are "forward-looking statements" that inherently involve substantial risks and uncertainties. These forward-looking statements are based on management's current expectations, and as a result of certain risks and uncertainties, actual results may differ materially from those provided. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: the potential impacts of economic conditions on Dolby's business operations, financial results, and financial position (including the impact to Dolby partners and disruption of the supply chain and delays in shipments of consumer products; the level at which Dolby technologies are incorporated into products and the consumer demand for such products; delays in the development and release of new products or services that contain Dolby technologies; delays in royalty reporting or delinquent payment by partners or licensees; lengthening sales cycles; the impact to the overall cinema market including adverse impact to Dolby's revenue recognized on box-office sales and demand for cinema products and services; and macroeconomic conditions that affect discretionary spending and access to products that contain Dolby technologies); risks associated with geopolitical issues and international conflicts; risks associated with trends in the markets in which Dolby operates, including the broadcast, mobile, consumer electronics, PC, and other markets; the loss of, or reduction in sales by, a key customer, partner, or licensee? pricing pressures? risks relating to changing trends in the way that content is distributed and consumed; risks relating to conducting business internationally, including trade restrictions and changes in diplomatic or trade relationships; risks relating to maintaining patent coverage? the timing of Dolby's receipt of royalty reports and payments from its licensees, including recoveries? changes in tax regulations; timing of revenue recognition under licensing agreements and other contractual arrangements? Dolby's ability to develop, maintain, and strengthen relationships with industry participants? Dolby's ability to develop and deliver innovative products and technologies in response to new and growing markets? competitive risks? risks associated with conducting business in countries that have historically limited recognition and enforcement of intellectual property and contractual rights? risks associated with the health of the motion picture and cinema industries generally? Dolby's ability to increase its revenue streams and to expand its business generally, and to continue to expand its business beyond its current technology offerings? risks associated with acquiring and successfully integrating businesses or technologies? and other risks detailed in Dolby's SEC filings and reports, including the risks identified under the section captioned "Risk Factors" in its Quarterly Report on Form 10-Q filed on or around the date hereof. Dolby may not actually achieve the plans, intentions, or expectations disclosed in its forward-looking statements. Forward-looking statements are based upon information available to us as of the date of such statements, and while Dolby believes such information forms a reasonable basis for such statements, such information may be limited or incomplete. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. Except as required by law, Dolby disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.

About Dolby

Dolby Laboratories (NYSE: DLB) is a world leader in immersive entertainment. From movies and TV, to music, sports, gaming, and beyond, Dolby transforms the science of sight and sound into spectacular experiences for billions of people worldwide across all their favorite devices. We partner with artists, storytellers, and the brands you love to transform entertainment and digital experiences through groundbreaking innovations like Dolby Atmos, Dolby Vision, Dolby Cinema, and Dolby OptiView.

Dolby, Dolby Atmos, Dolby Vision, Dolby Cinema, Dolby OptiView, and the double-D symbol are among the registered and unregistered trademarks of Dolby Laboratories in the United States and/or other countries. Other trademarks remain the property of their respective owners.

                                             
        
          DOLBY LABORATORIES, INC.

                             
        
          INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

                                     
        (in thousands, except per share amounts; unaudited)




                                                                                                                      Fiscal Quarter Ended


                                                                                                         December 26,                      December 27,
                                                                                                                 2025                               2024



 
          Revenue:



   Licensing                                                                                                $319,771                           $330,479



   Products and services                                                                                      26,935                             26,520



 Total revenue                                                                                               346,706                            356,999





 
          Cost of revenue:



   Cost of licensing                                                                                          20,762                             21,110



   Cost of products and services                                                                              22,446                             19,664



 Total cost of revenue                                                                                        43,208                             40,774





 
          Gross profit                                                                                     303,498                            316,225





 
          Operating expenses:



   Research and development                                                                                   69,077                             66,638



   Sales and marketing                                                                                        91,552                             94,399



   General and administrative                                                                                 70,243                             70,092



   Restructuring charges                                                                                      10,466                              5,216



 Total operating expenses                                                                                    241,338                            236,345





 
          Operating income                                                                                  62,160                             79,880





 
          Other income/(expense):



   Interest income/(expense), net                                                                              4,118                              2,646



   Other income, net                                                                                           5,324                              3,525



 Total other income                                                                                            9,442                              6,171





 Income before income taxes                                                                                   71,602                             86,051



   Provision for income taxes                                                                               (17,921)                          (17,981)



 Net income including noncontrolling interest                                                                 53,681                             68,070



   Less: net income attributable to noncontrolling interest                                                    (354)                             (248)



 
          Net income attributable to Dolby Laboratories, Inc.                                              $53,327                            $67,822





 Net income per share:



   Basic                                                                                                       $0.56                              $0.71



   Diluted                                                                                                     $0.55                              $0.70



 Weighted-average shares outstanding:



   Basic                                                                                                      95,466                             95,615



   Diluted                                                                                                    96,518                             97,147

                                      
          
            DOLBY LABORATORIES, INC.

                           
          
            INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS

                                            
          (in thousands; unaudited)




                                                                                                 December 26, September 26,
                                                                                                         2025           2025



 
            ASSETS



 Current assets:



 Cash and cash equivalents                                                                          $643,845       $701,893



 Restricted cash                                                                                      83,721         91,468



 Short-term investments                                                                                  739            703



 Accounts receivable, net                                                                            373,091        331,096



 Contract assets, net                                                                                198,266        180,804



 Inventories, net                                                                                     31,264         30,424



 Prepaid expenses and other current assets                                                            77,136         51,873



 Total current assets                                                                              1,408,062      1,388,261



 Long-term investments                                                                                85,022         80,205



 Property, plant, and equipment, net                                                                 466,720        470,608



 Operating lease right-of-use assets                                                                  35,569         33,204



 Goodwill and intangible assets, net                                                                 894,320        926,957



 Deferred taxes                                                                                      214,346        214,361



 Other non-current assets                                                                             88,084        114,164



 
            Total assets                                                                        $3,192,123     $3,227,760





 
            LIABILITIES AND STOCKHOLDERS' EQUITY



 Current liabilities:



 Accounts payable                                                                                     $8,668        $17,840



 Accrued liabilities                                                                                 376,212        369,256



 Income taxes payable                                                                                 11,208          8,928



 Contract liabilities                                                                                 37,094         31,382



 Operating lease liabilities                                                                          10,325         10,384



 Total current liabilities                                                                           443,507        437,790



 Non-current contract liabilities                                                                     25,159         29,687



 Non-current operating lease liabilities                                                              30,314         28,494



 Other non-current liabilities                                                                        90,272         99,843



 Total liabilities                                                                                   589,252        595,814





 Stockholders' equity:



 Class A common stock                                                                                     54             54



 Class B common stock                                                                                     40             40



 Retained earnings                                                                                 2,604,358      2,634,980



 Accumulated other comprehensive loss                                                               (10,777)      (12,517)



 Total stockholders' equity - Dolby Laboratories, Inc.                                             2,593,675      2,622,557



 Noncontrolling interest                                                                               9,196          9,389



 Total stockholders' equity                                                                        2,602,871      2,631,946



 
            Total liabilities and stockholders' equity                                          $3,192,123     $3,227,760

                                                                                 
          
            DOLBY LABORATORIES, INC.

                                                                 
          
            INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

                                                                                       
          (in thousands; unaudited)




                                                                                                                                                              Fiscal Quarter Ended


                                                                                                                                                 December 26,                      December 27,
                                                                                                                                                         2025                               2024



 
            Operating activities:



 Net income including noncontrolling interest                                                                                                        $53,681                            $68,070



 Adjustments to reconcile net income to net cash provided by operating activities:



   Depreciation and amortization                                                                                                                      24,145                             22,362



   Stock-based compensation                                                                                                                           37,211                             36,070



   Amortization of operating lease right-of-use assets                                                                                                 2,668                              2,835



   Provision for credit losses                                                                                                                           792                                730



   Deferred income taxes                                                                                                                                  16                            (7,307)



   Share of net income of equity method investees, net of cash distributions                                                                         (5,276)                             (911)



   Other non-cash items affecting net income                                                                                                         (1,890)                             1,191



   Changes in operating assets and liabilities:



   Accounts receivable, net                                                                                                                         (82,956)                          (24,647)



   Contract assets, net                                                                                                                             (19,824)                          (23,416)



   Inventories                                                                                                                                           879                              1,340



   Operating lease right-of-use assets                                                                                                               (4,810)                           (2,487)



   Prepaid expenses and other assets                                                                                                                 (3,152)                            13,528



   Accounts payable and accrued liabilities                                                                                                           43,575                              4,804



   Income taxes, net                                                                                                                                   4,394                             15,305



   Contract liabilities                                                                                                                                6,828                              3,691



   Operating lease liabilities                                                                                                                         1,552                              (798)



   Other non-current liabilities                                                                                                                     (3,034)                           (3,581)



 Net cash provided by operating activities                                                                                                            54,799                            106,779





 
            Investing activities:



   Proceeds from sale of intangible assets                                                                                                             6,623



   Purchases of property, plant, and equipment                                                                                                       (4,628)                           (6,779)



   Business combinations, net of cash and restricted cash acquired, and other related payments                                                             -                           (1,362)



   Purchases of intangible assets                                                                                                                      (750)



 Net cash provided by/(used in) investing activities                                                                                                   1,245                            (8,141)





 
            Financing activities:



   Proceeds from issuance of common stock                                                                                                             14,253                             22,157



   Repurchase of common stock                                                                                                                       (70,005)                          (15,000)



   Payment of cash dividend                                                                                                                         (34,339)                          (31,548)



   Distributions to noncontrolling interest                                                                                                            (547)                             (740)



   Shares repurchased for tax withholdings on vesting of restricted stock                                                                           (31,196)                          (32,440)



 Net cash used in financing activities                                                                                                             (121,834)                          (57,571)





   Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash                                                                (5)                           (7,162)



 Net increase/(decrease) in cash, cash equivalents, and restricted cash                                                                             (65,795)                            33,905



 Cash, cash equivalents, and restricted cash at beginning of period                                                                                  793,361                            577,752



 Cash, cash equivalents, and restricted cash at end of period                                                                                       $727,566                           $611,657

                                                             
          
            Licensing Revenue by Market

                                                                     
          
            (unaudited)





          The following table presents the composition of our licensing revenue and percentage of total licensing revenue for all periods presented (in thousands,
except percentage amounts):




                                                                                                                     
          
            Fiscal Quarter Ended



          
            
              Market                                                                           December 26, 2025                             December 27, 2024



          Broadcast                                                                                                $100,263           31 %                         $115,762           35 %



          Mobile                                                                                                     74,949           23 %                           61,524           19 %



          CE                                                                                                         45,602           14 %                           49,457           15 %



          PC                                                                                                         28,717            9 %                           31,256            9 %



          Other                                                                                                      70,240           23 %                           72,480           22 %



          
            Total licensing revenue                                                                     $319,771          100 %                         $330,479          100 %

                                                                                        
          
            GAAP to Non-GAAP Reconciliations


                                                                                                  
          
            (unaudited)





          The following tables present Dolby's GAAP financial measures reconciled to the non-GAAP financial measures included in this release for the first
quarters of fiscal 2026 and fiscal 2025:





          
            Net income:                                                                                                                                       Fiscal Quarter Ended



          
            (in thousands)                                                                                                                       December 26,                      December 27,
                                                                                                                                                                     2025                               2024



          GAAP net income attributable to Dolby Laboratories, Inc.                                                                                               $53,327                            $67,822



          Stock-based compensation (1)                                                                                                                            37,211                             36,070



          Amortization of acquisition-related intangibles (2)                                                                                                      9,867                             10,647



          Restructuring charges                                                                                                                                   10,466                              5,216



          Income tax adjustments                                                                                                                                 (8,370)                           (8,886)



          Non-GAAP net income attributable to Dolby Laboratories, Inc.                                                                                          $102,501                           $110,869





          (1) Stock-based compensation included in above line items:



          Cost of products and services                                                                                                                             $530                               $487



          Research and development                                                                                                                                11,568                             10,984



          Sales and marketing                                                                                                                                     12,705                             12,645



          General and administrative                                                                                                                              12,408                             11,954





          (2) Amortization of acquisition-related intangibles included in above line items:



          Cost of licensing                                                                                                                                       $6,590                             $6,704



          Cost of products and services                                                                                                                              768                                834



          Sales and marketing                                                                                                                                        353                                754



          General and administrative                                                                                                                               1,715                              1,872



          Other income, net                                                                                                                                          441                                483





          
            Diluted earnings per share:                                                                                                                       Fiscal Quarter Ended


                                                                                                                                                             December 26,                      December 27,
                                                                                                                                                                     2025                               2024



          GAAP diluted earnings per share                                                                                                                          $0.55                              $0.70



          Stock-based compensation                                                                                                                                  0.39                               0.37



          Amortization of acquisition-related intangibles                                                                                                           0.10                               0.11



          Restructuring charges                                                                                                                                     0.11                               0.05



          Income tax adjustments                                                                                                                                  (0.09)                            (0.09)



          Non-GAAP diluted earnings per share                                                                                                                      $1.06                              $1.14





          Weighted-average shares outstanding - diluted (in thousands)                                                                                            96,518                             97,147




          The following tables present a reconciliation between GAAP and non-GAAP versions of the estimated financial measures for the second quarter of
fiscal 2026 and full year fiscal 2026 included in this release:





          
            Gross margin:                                                                                                                                        Q2 2026                         Fiscal 2026



          GAAP gross margin                                                                                                                                                  90.0 %                              88.0 %



          Stock-based compensation                                                                                                                                            0.1 %                               0.1 %



          Amortization of acquisition-related intangibles                                                                                                                     0.9 %                               1.9 %




          Non-GAAP gross margin                                                                                                                                              91.0 %                              90.0 %






          
            Operating expenses (in millions):                                                                                                                    Q2 2026                         Fiscal 2026




          GAAP operating expenses (low - high end of range)                                                                                                      
      $230 - $240                  
      $930 - $950



          Stock-based compensation                                                                                                                                             (31)                               (128)



          Amortization of acquisition-related intangibles                                                                                                                       (2)                                (10)



          Restructuring charges                                                                                                                                                 (2)                                (12)




          Non-GAAP operating expenses (low - high end of range)                                                                                                  
      $195 - $205                  
      $780 - $800






          
            Operating margin:                                                                                                                                                                  Fiscal 2026




          GAAP operating margin                                                                                                                                                                                 21% +/-



          Stock-based compensation                                                                                                                                                                                  9 %



          Amortization of acquisition-related intangibles                                                                                                                                                           3 %



          Restructuring charges                                                                                                                                                                                     1 %




          Non-GAAP operating margin                                                                                                                                                                             34% +/-






          
            Effective tax rate:                                                                                                                                  Q2 2026                         Fiscal 2026




          GAAP effective tax rate                                                                                                                                            23.0 %                              23.0 %



          Stock-based compensation (low - high end of range)                                                                                                              (2%) - 1%                          (2%) - 0%



          Amortization of acquisition-related intangibles (low - high end of range)                                                                                       (1%) - 0%                          (1%) - 0%




          Non-GAAP effective tax rate                                                                                                                                        21.0 %                              21.0 %






          
            Diluted earnings per share:                                                                                                              Q2 2026                       Fiscal 2026



                                                                                                                                                             Low               High      Low                     High




          GAAP diluted earnings per share (low - high end of range)                                                                                       $0.94                $1.09    $2.71                        $2.86



          Stock-based compensation                                                                                                                         0.32                 0.32     1.34                         1.34



          Amortization of acquisition-related intangibles                                                                                                  0.11                 0.11     0.43                         0.43



          Restructuring charges                                                                                                                            0.02                 0.02     0.13                         0.13



          Income tax adjustments                                                                                                                         (0.10)              (0.10)  (0.31)                      (0.31)




          Non-GAAP diluted earnings per share (low - high end of range)                                                                                   $1.29                $1.44    $4.30                        $4.45






          Weighted-average shares outstanding - diluted (in thousands)                                                                                   95,900               95,900   95,700                       95,700

Investor Contact:
Peter Goldmacher
415-254-7415
peter.goldmacher@dolby.com

Media Contact:
media@dolby.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/dolby-laboratories-reports-first-quarter-2026-financial-results-302674379.html

SOURCE Dolby Laboratories, Inc.

© 2026 Canjex Publishing Ltd. All rights reserved.